Biopharma Adaptive Trials on THREAD Now Enrolling
Several new global adaptive clinical studies designed with THREAD have launched and are actively enrolling patients today.
Since announcing the solution earlier this year, sponsors and CROs have used THREAD’s configurable, no-code platform to support Phase Ib–IV trials and registries with complex cohorts, treatment arms, participant pathways, and protocol adaptations.
THREAD helps research teams by providing:
- Configurable participant pathways across multiple cohorts and treatment arms
- Rapid implementation of protocol adaptations
- Role-based governance for participant transitions
- Automated visits, tasks, and participant workflows
- A single study configuration that can evolve with the trial
As regulatory initiatives continue to support more efficient approaches to evidence generation, adaptive trial designs offer sponsors additional flexibility to optimize enrollment, resources, and study execution while maintaining rigorous scientific standards.
Read the latest announcement and learn how THREAD can support your next adaptive clinical trial. Read the announcement